Brian T. Bateman, MD, MSc

  • 2Articles
  • 21.9KReads
  • 2019–2023Active
  • 21Collaborators
  • 35Citations

About

Brian T. Bateman, MD, MSc, is affiliated with the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital and Harvard Medical School, as well as the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. His publications in Psychiatrist.com focus on mood disorders and women's health, specifically examining the use of medications such as atomoxetine and anticonvulsant mood stabilizers during pregnancy and their associated risks. His work spans from 2019 to 2023 and includes collaborations with researchers like Helen Mogun and Krista F. Huybrechts.

Publications

JCP
Atomoxetine and Prevalence of Major Congenital Malformations
Original Research

Atomoxetine and Prevalence of Major Congenital Malformations

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ January 16, 2023

Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.
, , , et al
JCP
Original Research

Mood Stabilizers and Placenta-Mediated Complications

June 18, 2019

Women who take mood stabilizers have a greater risk of placenta-mediated pregnancy complications. But are the mood stabilizers themselves responsible for this higher risk? This study explores that question.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe